Stay updated on Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.3 and the entries for HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. These are site maintenance metadata changes and do not alter trial data.
    Difference
    0.2%
    Check dated 2025-12-23T10:17:13.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The Record History now lists a new revision tag (v3.3.2) and removes v3.3.1, which is a metadata update to the history log rather than a change to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:09:28.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Version history shows a new revision (v3.3.1) with sponsor naming updated to BeOne Medicines (BeiGene) and status/identification updates. The previous sponsor entry BeiGene and the earlier revision v3.2.0 are listed as deletions.
    Difference
    0.7%
    Check dated 2025-11-24T13:51:54.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Removed a banner notice about government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T06:31:49.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    Version 11 was posted on 2025-04-11, updating the record with changes to the study status and IPD sharing information for NCT04379635.
    Difference
    0.1%
    Check dated 2025-11-03T01:12:49.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    12%
    Check dated 2025-10-05T10:04:04.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs. Standard Treatment in NSCLC Clinical Trial page.